• Ablexis Announces Further Expansion of Its Intellectual Property on AlivaMab® Mouse and Immunoglobulin Locus Engineering

    9 days ago - By San Diego Biotechnology

    SAN DIEGO--Ablexis, LLC, a biopharmaceutical company focused on licensing its transgenic mouse platforms for antibody drug discovery, today announced further expansion of its intellectual property portfolio directed to its AlivaMab Mou......
    Read more ...